Renal Business Today

Amgen to Pay $24.9 Million to Resolve False Claims Act Allegations Act Allegations

THOUSAND OAKS, Calif.—Amgen Inc., a California-based biotechnology company, has agreed to pay the United States $24.9 million to settle allegations that it violated the False Claims Act, the Justice Department announced. ...More

April 17, 2013

Posted in News, Business

Amgen Outlines Long-Term Business Strategy for 2013 to 2016

NEW YORK—Amgen outlined the company's long-term strategy during a Business Review meeting with analysts and investors in New York City. ...More

February 7, 2013

Posted in News, Business, Clinical & Pharma

Amgen Releases 2012 Revenue

THOUSAND OAKS, Calif.—Amgen announced financial results for the fourth quarter and full year of 2012. ...More

January 24, 2013

Posted in News, Business

Amgen Announces Webcast of 2012 Fourth Quarter and Full Year Financial Results

THOUSAND OAKS, Calif.—Amgen announced that it will report its fourth quarter and full year 2012 financial results on Wednesday, January 23 after the close of the financial markets. The announcement will be followed by a conference call with the investment community at 2 ...More

January 18, 2013

Posted in News, Business

Amgen To Build State-Of-The-Art Manufacturing Facility In Singapore

THOUSAND OAKS, Calif.—Amgen announced plans to build a new manufacturing facility in the Tuas Biomedical Park area of Singapore. Over the next several years, Amgen anticipates investing approximately $200 million to build an innovative new facility, which will initially ...More

January 16, 2013

Posted in News, Business, Clinical & Pharma

Amgen Pleads Guilty, Finalizes Settlement

THOUSAND OAKS, Calif.—Amgen announced it has finalized a settlement agreement with the U.S. government, 49 states and the District of Columbia related to previously disclosed investigations. ...More

December 19, 2012

Posted in News, Government & Regulation

Current Director Vance D. Coffman Named Lead Independent Director

THOUSAND OAKS, Calif.—Amgen announced appointments to its board of directors. Robert A. Bradway, chief executive officer, has been appointed chairman of the board, and Vance D. Coffman, an Amgen director since 2007, has been appointed lead independent director, both ...More

December 14, 2012

Posted in News, Business

Amgen Announces Appointment of Robert A. Eckert to Board of Directors

THOUSAND OAKS, Calif.—Amgen announced the appointment of Robert A. Eckert, former chief executive officer at Mattel, Inc., to its board of directors. Eckert will serve on the Audit and Corporate Responsibility and Compliance Committees of the board. Following the ...More

December 14, 2012

Posted in News, Business

Amgen Announces Increase in 2013 First Quarter Dividend, Increase in Share Repurchase Authorization

THOUSAND OAKS, Calif.—Amgen announced that its Board of Directors today declared a $0.47 per share dividend for the first quarter of 2013. The dividend will be paid on March 7, 2013, to all stockholders of record as of the close of business on February 13. ...More

December 14, 2012

Posted in News, Business

Amgen, deCODE Genetics Merge to Identify and Validate Disease Targets in Human Populations

THOUSAND OAKS, Calif. and REYKJAVIK, Iceland—Amgen and deCODE Genetics announced that the companies have entered into a definitive agreement under which Amgen will acquire deCODE Genetics, a global leader in human genetics, headquartered in Reykjavik, Iceland. The all-cash ...More

December 10, 2012

Posted in News, Business

Computers & Software	Consulting, Management...
Equipment & Services	Hemodialysis Supplies
Patient Services	More Options...

Amgen

Video Snapshot

Galleries

RBT Poll

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail